Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Taiwan Semiconductor Mfg. Co. Ltd. (TSM) vs Twist Bioscience Corp (TWST) Price & Performance

Taiwan Semiconductor Mfg. Co. Ltd.Trade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Taiwan Semiconductor Mfg. Co. Ltd. vs Twist Bioscience Corp — how do they compare? Taiwan Semiconductor Mfg. Co. Ltd. trades at $425.29 (market cap $1.88T), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Taiwan Semiconductor Mfg. Co. Ltd. is far larger — about 345× Twist Bioscience Corp's market cap, and Taiwan Semiconductor Mfg. Co. Ltd. pays a 0.94% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.

TSMTWST
Market Cap
$1.88T$5.45B
Sector
TechnologyHealth
52-Week High
$477.57$102.88
52-Week Low
$227.33$24.16
Enterprise Value
$1.81T$5.37B
Dividend Yield
0.94%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Taiwan Semiconductor Mfg. Co. Ltd.

Taiwan Semiconductor Manufacturing Company, or TSMC, is the world's largest dedicated chip foundry, with over 57% market share in 2021 per Gartner. TSMC was founded in 1987 as a joint venture of Philips, the government of Taiwan, and private investors. It went public as an ADR in the U.S. in 1997. TSMC's scale and high-quality technology allow the firm to generate solid operating margins, even in the highly competitive foundry business. Furthermore, the shift to the fabless business model has created tailwinds for TSMC. The foundry leader has an illustrious customer base, including Apple, AMD and Nvidia, that looks to apply cutting-edge process technologies to its semiconductor designs.

Read more on TSM

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST